FDA Inspection
Grifols Diagnostic Solutions Inc.Grifols Diagnostic Solutions Inc. – FDA Inspection, May 24, 2012
Record Details
This FDA Inspection record concerns Grifols Diagnostic Solutions Inc., with an inspection on May 24, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- May 24, 2012
- Product Type
- Biologics
View Company Profile
ID · 8c3567fa-205b-4024-b49d-e7a350256874
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 784225
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Grifols Diagnostic Solutions Inc.
11| Date | Classification | Office | Project area |
|---|---|---|---|
| October 31, 2025 | VAI | San Francisco District Office | Blood and Blood Products |
| December 13, 2024 | Not classified | San Francisco District Office | |
| December 7, 2021 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| February 15, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 28, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Grifols Diagnostic Solutions Inc.
- FDA Inspection 1289592 - 2025-10-31
- FDA Inspection 1258104 - 2024-12-13
- FDA Inspection 1162064 - 2021-12-07
- FDA Inspection 1079880 - 2019-02-15
- FDA Inspection 991586 - 2016-09-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.